Ethyl pyruvate (EP), a simple aliphatic ester of pyruvic acid, has been shown to have antiinflammatory effects and to confer protective effects in various pathological conditions. Recently, a number of studies have reported EP inhibits high mobility group box 1 (HMGB1) secretion and suggest this might contribute to its antiinflammatory effect. -mediated kinases (protein kinase Cα and calcium/calmodulin-dependent protein kinase IV), HMGB1 phosphorylation and subsequent secretion of HMGB1 also were suppressed. (A23187 is a calcium ionophore and BV2 cells are a microglia cell line.) Moreover, the above-mentioned EP-mediated effects were obtained independent of cell death or survival, which suggests that they are direct effects of EP . Together, these results indicate that EP directly chelates Ca 2+ , and that it is, at least in part, responsible for the suppression of HMGB1 release by EP . 
INTRODUCTION
Ethyl pyruvate (EP) is a simple aliphatic ester of pyruvic acid and has been shown to confer protective effects in various disease models. For example, EP administration improved survival in lethal models of hemorrhagic shock and diminished ischemia-induced myocardial injury (1, 2) . EP also significantly reduced infarct volumes in the postischemic brain (3) and attenuated kainic acid-induced neuronal cell death in the CA1 and CA3 regions of the mouse hippocampus (4) . In addition, EP has been reported to attenuate experimental severe acute pancreatitis (5) and to improve motor function scores in models of spinal cord ischemia and traumatic brain injury (6, 7) .
The protective effects of EP have been attributed to its antiinflammatory, antioxidative and antiapoptotic effects. Regarding its antiinflammatory effects, various molecular mechanisms have been suggested. Inhibition of the DNA binding of p65 (a nuclear factor [NF]-κB subunit) by EP via decreasing intracellular glutathione (GSH) levels has been reported (8) , which results in changing the intracellular redox conditions to favor the oxidation of the key cysteine residue in p65. Covalent modification of p65 by EP also has been reported (9) . EP not only suppresses proinflammatory cytokine production via NF-κB inhibition (10, 11) but also was found to increase the production of antiinflammatory cytokines in lipopolysaccharide (LPS)-injected-rat model and ischemic rat model (1, 3) . Furthermore, it has been reported that the antiinflammatory effect of EP is attributable to the inhibition of reactive oxygen species (ROS)-dependent signal transducer and activator of transcription (STAT) signaling (12) . In addition, we recently reported that EP induced p300 sequestration by Nrf2-suppressed p65 activation (13) , which suggests a link exists Tae-Kyung Kim, 3 Chang-Kook Suh, 4 Jiyeon Kwak, 4 Keun-Hyeung Lee, 2 Pyung-Lim Han, 3 and Ja-Kyeong Lee HMGB1 release. Calcium imaging assays revealed that EP significantly and dose-dependently suppressed high K + -induced transient [Ca 2+ ] i surges in primary cortical neurons and, similarly, fluorometric assays showed that EP directly scavenges Ca 2+ as the peak of fluorescence emission intensities of Mag-Fura-2 (a low-affinity Ca 2+ indicator) was shifted in the presence of EP at concentrations of ≥7 mmol/L. Furthermore, EP markedly suppressed the A23187-induced intracellular Ca 2+ surge in BV2 cells and, under this condition, A23187-induced activations of Ca
2+
-mediated kinases (protein kinase Cα and calcium/calmodulin-dependent protein kinase IV), HMGB1 phosphorylation and subsequent secretion of HMGB1 also were suppressed. (A23187 is a calcium ionophore and BV2 cells are a microglia cell line.) Moreover, the above-mentioned EP-mediated effects were obtained independent of cell death or survival, which suggests that they are direct effects of EP . Together, these results indicate that EP directly chelates Ca
, and that it is, at least in part, responsible for the suppression of HMGB1 release by EP . between the antiinflammatory and antioxidative functions of EP.
A number of reports have demonstrated that EP inhibits HMGB1 secretion and that this contributes to its antiinflammatory effects (14) (15) (16) (17) (18) . HMGB1 is an endogenous danger signal molecule and extracellular HMGB1 induces the secretions of various proinflammatory cytokines and aggravates inflammatory processes (19, 20) . The secretory mechanism involved has been investigated (21) and has shown that serine phosphorylation of HMGB1 is essential for its translocation from the nucleus to cytoplasm. Furthermore, the activations of two calcium-mediated protein kinases, that is, classical protein kinase C (cPKC) and calcium/calmodulin-dependent protein kinase type IV (CaMKIV), have been reported to play critical roles in the phosphorylation of HMGB1 (22, 23) .
EP is used in a Ca
-containing balanced salt solution (Ringer-EP solution), in which two molecules of EP associate with Ca
. In the present study, we examined whether EP directly chelates Ca 2+ , and whether this chelation is responsible for the EP-mediated suppression of HMGB1 release. 
MATERIALS AND METHODS

EP
Primary Cortical Cultures
Experiments were carried out in strict accordance with the recommendations made in the Guide for the Care and Use of Laboratory Animals published by the National Institute of Health (24) . The animal protocol used in this study was reviewed and approved by the INHA UniversityInstitutional Animal Care and Use Committee (INHA-IACUC) with respect to ethicality (approval number INHA-130607-209). Primary cortical cultures were prepared from embryonic d-15.5 mouse cortices and cultured as described previously (25) . were washed three times for 30 min each to allow deesterification of the acetoxymethyl ester. Cells were viewed under a Nikon Diapot microscope (DIAPOT-300) (Nikon Corporation, Tokyo, Japan) attached with a CCD camera (PXL-37) (Photometrics, Tucson, AZ, USA). Light was generated using a xenon lamp and filtered through 340-or 380-nm filters. Fluorescence intensities were measured using a 510-nm filter using a cooled CCD digital camera (PXL-37) (Photometrics 
Preparation of Cell Extracts and Protein Contents in Media
Nuclear and cytosolic extracts were prepared using NE-PER nuclear and cytoplasmic extraction reagents (Thermo Fisher Scientific), according to the manufacturer's instructions. To prepare protein from culture media, media were centrifuged at 500g for 5 min to remove cellular debris. Supernatants were collected and concentrated using a Nanosep centrifugal device (Pall Life Sciences, Ann Arbor, MI, USA), according to the manufacturer's instructions.
Immunoblotting
Cells were washed twice with cold phosphate-buffered saline (PBS) and lysed using radioimmunoprecipitation assay (RIPA) buffer (50 mmol/L Tris-HCl (pH 7.4), 1% NP40, 0.25% sodium-deoxycholate, 150 mmol/L NaCL, 1 mmol/L Na 3 VO 4 and one mini-protease inhibitor cocktail tablet (Roche Diagnostics, Mannheim, Germany). Lysates were centrifuged at 14,000g for 15 min at 4°C and supernatants were then loaded onto 12% SDS-PAGE gels. The primary antibodies (diluted at 1:1000) used were as follows: anti-HMGB1 (ab67281) (Abcam, Cambridge, MA, USA) for cerebrospinal fluid (CSF) and media, anti-HMGB1 from (sc-56698) (Santa Cruz Biotechnology, Santa Cruz, CA, USA) for lysates, anti-inducible nitric oxide synthase (anti-iNOS) (Abcam), anti-PKCα (BD Biosciences, San Jose, CA, USA), anti-CaMKIV (BD Biosciences), anti-p62 (Santa Cruz Biotechnology), anti-lamin B (Santa Cruz Biotechnology), and anti-α-tubulin (Calbiochem [EMD Millipore]). Primary antibodies were detected using BM Chemiluminescence Blotting Substrate (Roche Diagnostics) and goat anti-rabbit, goat antimouse, and donkey anti-goat horseradish peroxidase-conjugated secondary antibodies (Millipore Bioscience Research Reagents, Temecula, CA, USA) were used.
Coimmunoprecipitation-Linked Immunoblotting
Total lysates containing 500 μg of protein were immunoprecipitated with 2 μL of anti-HMGB1 antibody (Abcam) overnight at 4°C. Preequilibrated protein G PLUS-Agarose beads (Santa Cruz Biotechnology) were then added and incubated for 2 h at 4°C on a rotating wheel. Beads were washed three times with RIPA buffer and the proteins so obtained were separated by SDS-PAGE. Anti-phospho-serine antibody (Millipore Bioscience Research Reagents) was used as the primary antibody at a dilution of 1:1000.
Cell Viabilities and NO Measurements
Cell viabilities after A23187 (a calcium ionophore) (Sigma-Aldrich) treatment (1, 2.5 or 5 μmol/L) were analyzed using the MTT (3-[4,5-dimethylthiaziazol-3-yl] 2,5-diphenyl tetrazolium bromide) method. Briefly, 24 h after A23187 treatment (1, 2.5 or 5 μmol/L, 30 min), cells were stained with 500 μg/mL MTT (Sigma-Aldrich). Media were then carefully aspirated and 200 μL of dimethyl sulfoxide (DMSO) was added to solubilize the colored formazan product. Optical densities were read at 550 nm. For lactate dehydrogenase (LDH) assay, 50 μL of A23187-treated media were mixed with same volume of LDH assay reagent (Roche Diagnostics) in a 96-well plate and incubated for 15 min. Optical densities were read at 490 nm. To measure the amount of NO produced by BV2 cells, 100 μL of conditioned medium was mixed with an equal volume of Griess reagent (0.5% sulfanilamide and 0.05% N-1-naphthylethylenediamine), and incubated for 10 min at room temperature. Absorbance of the mixture at 550 nm was measured using a microplate reader (BioTek Instruments Inc., Winooski, VT, USA).
Calcium Assay and Staining
BV2 cells were treated with 2.5 μmol/L of A23187 for 30 min and then incubated with 4 μmol/L of Flou-4 (Molecular Probes [Thermo Fisher Scientific]) for 30 min and rinsed twice with PBS Increased fluorescence excitation at 488 nm was determined by confocal microscopy (LSM 510 META) (Carl Zeiss MicroImaging Inc., Thornwood, NY, USA) and by using a fluorescence microplate reader (Luminmax-c luminometer; Maxwell Sensors Inc., Santa Fe Springs, CA, USA).
Measurement of Ca
2+ Chelating Activity Excitation spectra of mag-fura-2 (10 μmol/L) (Molecular Probes [Thermo Fisher Scientific]) in the presence of various concentration of CaCl 2 were measured in aqueous buffered solution (10 mmol/L MOPS, 120 mmol/L KCl, pH 7.15) using a LS55 Luminescence spectrometer (PerkinElmer Inc, Waltham, MA, USA). Fluorescence excitation spectra of mag-Fura-2 (10 μmol/L) and CaCl 2 (1 mmol/L) were measured in the same buffered solution in the presence of ethylenediaminetetraacetic acid (EDTA), EP and sodium pyruvate, respectively. Fluorescent excitation spectra detected at 510 nm were measured at 22°C and the slit widths for excitation and emission were 15 and 20 nm, respectively. Fluorescence excitation spectra were recorded from 250 nm to 450 nm (increment 0.5 nm). Data analysis was performed using FL WinLab software (PerkinElmer Inc).
Statistical Analysis
Two-sample comparisons were performed using the Student t test, while multiple comparisons were made using one-way or two-way analysis of variance (ANOVA) followed by post hoc test to compare selected pairs of data. PRISM software 5.0 (GraphPad Software Inc., La Jolla, CA, USA) was used to perform statistical analysis. All data are presented as mean ± SEM and statistical difference was accepted at the 5% level. ] i increase to 66.4 ± 2.5% (n = 44 cells, **p < 0.01) or 56.0 ± 2.0% (n = 50 cells, **p < 0.01) of the first response, respectively, indicating that EP suppressed [Ca 2+ ] i in a dose-dependent manner ( Figure 1C ).
RESULTS
EP
EP Directly Scavenged Ca
2+ under
Cell Free Conditions
To further confirm that EP directly chelates Ca 2+ , fluorescence spectra studies were conducted with mag-Fura-2 (low affinity Ca 2+ indicator). We first carried out the titration experiment of mag-fura-2 with CaCl 2 . As shown in Figure 2A , about 1 mmol/L CaCl 2 was enough to completely form the complex between mag-fura-2 (10 μmol/L) and Ca 2+ because the band at 370 nm corresponding to free mag-fura-2 decreased and the band at 330 nm corresponding to the complex increased. To confirm the chelating activity of EP for Ca 2+ , fluorescence excitation spectra of mag-Fura-2 (10 μmol/L) and CaCl 2 (1 mmol/L) were compared in the presence of EDTA, EP or sodium pyruvate. The addition of increasing amounts of EDTA as a wellknown Ca 2+ -chelating agent induced an increase of the band at 370 nm as well as a decrease of the band 330 nm, which indicated that EDTA removed calcium ions from mag-fura-2, resulting in the same spectrum of mag-fura-2 in the absence of Ca 2+ (Figures 2A, B) . Upon addition of an increasing amount of EP into the solution containing mag-fura-2 and CaCl 2 , the band at 330 nm decreased and the band at 367 nm increased at the concentration higher than 7 mmol/L ( Figure 2C ). This result suggests that EP, like EDTA, acts as a chelating agent, removing calcium ions from mag-fura-2. The chelating activity of EP was weaker than that of EDTA for Ca 2+ because almost 9-fold excess of EP fully removed Ca 2+ from mag-fura-2. However, upon addition of an increasing amount of sodium pyruvate into the solution containing mag-fura-2 and CaCl 2 , the band at 330 nm decreased but the band at 370 nm corresponding to free mag-fura-2 did not increase ( Figure 2D ), which suggested that pyruvate did not remove Ca 2+ from mag-fura-2. To investigate whether the decrease of the intensity at 330 nm may be due to the absorbance by pyruvate, excitation spectra of mag-fura-2 in the presence of sodium pyruvate without CaCl 2 were measured. The final spectrum of mag-fura-2 was almost the same as that of mag-fura-2 in the presence of sodium pyruvate with CaCl 2 (1 mmol/L) (Supplementary Figure S1) , which confirmed that the decrease of the intensity at 330 nm was due to the absorbance of a high concentration of pyruvate.
C H E L A T I O N O F C A L C I U M B Y E P I N H I B I T S H M G B 1 R E L E
A23187 Induced HMGB1 Secretion in BV2 Cells Without Causing Concomitant Activation or Cell Death
Recently, we reported that EP inhibits HMGB1 release in the postischemic brain and in BV2 cells (a microglia cell line) (18, 24) . In addition, we also showed that EP suppressed PKCα-or CaMKIVmediated HMGB1 phosphorylation in BV2 cells (18) . Efficient Ca 2+ chelation by EP prompted us to investigate the possibility that the inhibition of HMGB1 release by EP is due to the suppression of the Ca
2+
-induced activations of PKCα and CaMKIV. To find a culture condition that triggered HMGB1 secretion from BV2 cells without causing cell death, BV2 cells were cultured in media containing Ca 2+ ionophore (A23187; 1, 2.5 or 5 μmol/L) for 30 min in the presence of FBS (1%, 2.5% or 5%) and cell viabilities were examined 24 h later ( Figure 3A ). In the presence of 5% FBS, cell viabilities were maintained at 100% even when they were treated with 1 or 2.5 μmol/L of A23187 (n = 4) (see Figure 3A) . Complete survival and no activation of BV2 cells were confirmed by LDH ( Figure 3B ) and NO assays ( Figure 3C ), respectively. No activation of BV2 cells was further confirmed by showing that iNOS (see Figure 3C ) and proinflammatory marker expressions (Supplementary Figure S2) were also not changed after 1 or 2.5 μmol/L of A23187 treatment. However, under these conditions, HMGB1 secretion was detected at 3 h after A23187 treatment and HMGB1 continuously accumulated in culture media until 24 h with a concomitant decrease of HMGB1 in cell lysate ( Figure 3D ). These results indicate that treatment with 1 or 2.5 μmol/L of A23187 induced HMGB1 secretion from BV2 cells by increasing [Ca 2+ ] i without causing concomitant cell death or activation.
EP Blocked A23187-induced HMGB1 Secretion at the Level of Nuclear-toCytoplasmic Translocation
To determine whether EP inhibits A23187-induced HMGB1 secretion, BV2 cells were cotreated with 2.5 or 5 mmol/L of EP and A23187 (2.5 μmol/L) for 30 min and levels of HMGB1 in media, nuclear and cytoplasmic fractions were examined 24 h later. EP significantly blocked HMGB1 secretion at the level of nuclear-to-cytoplasmic translocation ( Figure 4A ). Similar inhibition of A23187-induced HMGB1 secretion by EP was also observed in RAW264.7 cells ( Figure 4B ). Together, these results indicate EP inhibits A23187-induced HMGB1 secretion at the level of nuclear to cytoplasmic translocation.
EP Suppressed A23187-Induced Intracellular Ca 2+ Increases in BV2 Cells
To examine whether EP suppresses A23187-induced intracellular Ca 2+ increase Figures 5A, B) . However, A23187-induced Flou-4 signals were reduced by cotreatment with EP (5 mmol/L) at all time points examined (n = 6, p < 0.01), suggesting Ca 2+ chelation by EP in BV2 cells (see Figures 5A, B) . To further confirm the ability of EP to chelate intracellular Ca
R E S E A R C H A R T I C L E M O L M E
2+
, EP (1, 2.5 or 5 mmol/L) was pretreated for 1 h, medium was washed out, and cells were incubated with A23187 for 30 min, and intracellular Fluo-4-positive fluorescence levels were measured at 1 h after A23187 treatment. As was expected, [Ca 2+ ] i levels were significantly reduced by EP pretreatment (n = 6, p < 0.01) (Figures 5C, D) , although the level of suppression observed was weaker than that observed for EP cotreatment at 1 and 5 mmol/L. These results indicate that EP chelates Ca 2+ in cytoplasm of BV2 cells and in media.
NMDA-Induced HMGB1 Secretion in Primary Cortical Cultures was Suppressed by Ca 2+ Chelation
It is well known that NMDA receptor activation induces long-lasting intracellular Ca 2+ elevation in neurons (26) . To demonstrate that Ca 2+ chelation by EP is involved in the suppression of HMGB1 release in more physiological contexts, levels of HMGB1 were examined in media obtained from NMDA -treated (100 μmol/L for 10 min or 50 μmol/L for 30 min) primary cortical cultures in the presence or absence of EP. At 24 h after NMDA treatment, HMGB1 accumulates in media of primary cortical cultures for both regimes ( Figure 6A ), which agrees with our previous report (27) . HMGB1 accumulations in media were markedly inhibited by cotreating NMDA with EP in a dose-dependent manner (see Figure 6A ). Similar inhibitions were observed after coor pretreating two well-known Ca 2+ chelators, EGTA and BAPTA-acetoxymethyl ester (BAPTA-AM), respectively, with NMDA (see Figure 6A ), suggesting that intracellular Ca 2+ chelation suppressed NMDA-induced HMGB1 release in neurons. To further confirm the intracellular Figure 7B ). Furthermore, HMGB1 phosphorylation at its serine residues, which began to increase after 1 h of A23187 treatment and peaked at 2 h (Figure 7C ), was markedly reduced by EP cotreatment in a dose-dependent manner ( Figure 7D) . Amounts of the precipitated proteins and input control were even in each lane, as evidenced by immunoblotting with anti-HMGB1 and anti-α-tubulin antibody (Figures 7C, D) . Importantly, the addition of 0.1 or 1 mmol/L CaCl 2 reversed the EP-mediated suppression of HMGB1 phosphorylation in A23187-treated cells, and this suppression was completely recovered by 1 mmol/L CaCl 2 ( Figure 7E ). Together these results indicate that EP suppresses the Ca 2+ -mediated activations of PKCα and CaMKIV and the phosphorylation of HMGB1.
C H E L A T I O N O F C A L C I U M B Y E P I N H I B I T S H M G B 1 R E L E
DISCUSSION
Accumulating evidence indicates that the suppression of HMGB1 secretion by EP contributes to the antiinflammatory effect of EP. In mice with established endotoxemia, sepsis and murine colitis, EP reduced circulating levels of HMGB1 and significantly prevented lethality (14, 16) and in mice with LPS-induced acute lung injury, EP also significantly suppressed HMGB1 release and reduced lung permeability indices and improved survival (28) . Recently, we also reported the suppression of HMGB1 phosphorylation and release by EP in BV2 cells and the suppression of HMGB1 release by EP in the postischemic brain (18) . In addition to the suppression of HMGB1 secretion, EP has been reported to inhibit HMGB1 expression in traumatic brain injury (7) and in myocardial ischemia/reperfusion injury models (2) . Accordingly, it appears that EP might provide a therapeutic means of ameliorating inflammatory responses by suppressing HMGB1 expression and secretion. To the best of our (35) , and these early events result in free radical excess, cell swelling, DNA fragmentation and cytoskeletal breakdown, leading to apoptotic and/or necrotic cell death (36) . Therefore, it can be postulated that in addition to the inhibition of HMGB1 release, various protective mechanisms emanating from Ca 2+ chelation by EP contribute to its protective effects. Therefore, the robust neuroprotective effect of EP in the postischemic (3) and in the postepileptic brain (4) could be due to a combination of its antiinflammatory, antioxidative and antiapoptotic effects, wherein the suppression of HMGB1 release contributes to its antiinflammatory effect.
CONCLUSION Q4
Although our fluorometric study showed direct chelation of Ca 2+ by EP (Figure 2) 
